The ABC's of Direct-to-Consumer (DTC) Ads
Bich-Nguyet Nguyen, Summer Student Intern 2000
and
Doctor of Pharmacy Candidate 2003
VCU / Medical College of Virginia
Direct-to-Consumer
(DTC) ads for prescription medicines are everywhere! Have
you seen the one for heartburn? How about the one for allergies?
You can read them in newspapers, magazines, on the Internet,
and you can even see them on TV. Do you read the fine print
or do you just look at the picture like most people do?
Most importantly, do you understand it?
According to pharmaceutical
consultants Scott-Levin, the pharmaceutical industry spent
$1.3 billion on DTC ads for prescription drugs in 1998.
Jupiter Communications, an on-line marketing research firm,
says it expects this to reach almost $3.8 billion by 2003.
What is a DTC
ad? A DTC ad is a pharmaceutical company's way of advertising
their medicines "direct to consumers." The DTC ads are designed
to give you easy access to medical information. By advertising
directly to you through magazines and TV, pharmaceutical
companies are encouraging you to become more active in your
medical care. The ads also provide information on newer
or more effective treatments for conditions for which you
may already being treated.
The purpose of
DTC ads is to get you to ask your doctor or pharmacist for
more information about the product. A good DTC ad will help
you think of the questions to ask your doctor before your
visit. But remember, your doctor is the only one who can
diagnose and prescribe the medicine for you. However, not
everyone needs the drug that is advertised. Therefore, do
not pressure your doctor to prescribe medicines being advertised
to you if the doctor thinks it is not the right one for
you.
How can you recognize
a DTC ad? The first part of the DTC ad looks very similar
to an ad for a car, cereal, or TV. For example, you might
see a field of wildflowers if the drug being advertised
is used to treat allergies. On the back of the ad, you will
find more detailed information about the medicine. The US
Food and Drug Administration (FDA) requires companies to
fully inform consumers about the risks and benefits of the
medicine. The FDA accepts either a Brief Summary or a Patient
Package Insert (PPI) on the back of a DTC ad.
The Brief Summary
was originally written for doctors and pharmacists and is
very technical. It was never intended for consumers. In
fact, studies show that only 31% of consumers even bother
to read the Brief Summary.
Some drug companies
are now realizing how important it is for consumers to be
able to understand this information. Consumers need to know
how to take the medicines and how to recognize the early
stages of side effects. Instead of a Brief Summary, these
companies are developing PPIs. PPIs still contain all the
information on risks and benefits required by the FDA, but
the information is written in everyday language the average
consumer can understand. You can trust this information.
Here are some
tips to help you make the best use of the information in
a DTC ad.
The next time you read a DTC ad, don't
rule out the ad as biased advertising. If it has a PPI that
is written in language you can understand, you know that company
has your best interests at heart. Every PPI has been approved
by the FDA and could be one of more reliable sources of information
about your medicine.
© 2000 Consumer
Health Information Corporation. All rights reserved.